Cryptococcus neoformans (Sanfelice) Vuillemin (ATCC® 90112)

Alternate State: Filobasidiella neoformans Kwon-Chung  /  Strain Designations: 7588/9.854 MCV 3 [NCCLS 88]  /  Product Format: freeze-dried

Deposited As Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph
Strain Designations 7588/9.854 MCV 3 [NCCLS 88]
Alternate State Filobasidiella neoformans Kwon-Chung
Application
susceptibility testing
susceptibility testing antifungal agents
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level 2
Product Format freeze-dried
Type Strain no
Preceptrol® no
Comments
Synergistic effect of combination of fluconazole and flucytosine
Medium Medium 200: YM agar or YM broth
Growth Conditions
Temperature: 24.0°C
Name of Depositor A Espinel-Ingroff
Isolation
cerebrospinal fluid, Pennsylvania
References

Espinel-Ingroff A, et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30: 3138-3145, 1992. PubMed: 1452697

Nguyen MH, et al. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob. Agents Chemother. 39: 1691-1695, 1995. PubMed: 7486902

Medical microbiology--Susceptibility testing of microbial pathogens to antimicrobial agents -- Part 84: Microdilution; Special requirements for testing of fungi against antifungal agents. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58940-84: 2002, 2002